MedicalDevice Licensing.com
Innovaro Pharmalicensing
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Innovaro Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Pay-per-Click New!
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Innovaro Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd
Innovaro Corporation
Articles

Innovaro Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

Displaying 11..20 of 21 - per page Previous page Next page
Order by
The characteristic appearance and movement of a patient with advanced Parkinson's Disease are the stooped and rigid posture, shuffling gait, tremor, and constant movement of the thumb and forefinger described as 'pill-rolling' More
Alzheimer's disease continues to be an affliction for which an effectivetherapy has been hard to pin down. More
For years the pharmacological management of stroke languished in the shadows cast by heart dent developments this could soon change. More
Essentially, migraine is a severe pain in the head, usually one-sided, that is frequently associated with nausea and vomiting. More
MND is a devastating neurological disorder that robs people of their More
A detailed look at the different aspects of panic disorder More
A 'stroke' is a fairly innocuous term for what can be a terrifying medical emergency - perhaps the American use of 'brain attack' is more appropriate. More
Multiple sclerosis (MS) is a slowly progressive disease of the central nervous system characterised by inflammation and demyelination of white matter in the brain and spinal cord. More
This interview with Neurotech's Executive Vice President and Chief Financial Officer looks at the company's funding and development. More
It can be argued that the pharmaceutical industry was brought into being by Friedrich Serturner's isolation of morphine, the main active ingredient of opium, at the beginning of the 19th century. More
Displaying 11..20 of 21 - per page Previous page Next page
Order by

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Innovaro Pharmalicensing current industry press releases.

© Copyright 1998-2010 Innovaro Pharmalicensing, a division of Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us